Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Nulibry Now Available for Molybdenum Cofactor Deficiency Type A
AAN: Race May Affect Response to Anti-CD20 Therapy for MS, NMOSD
Ponvory Now Available for Relapsing Forms of Multiple Sclerosis
Pamrevlumab Fast Tracked for Duchenne Muscular Dystrophy
Xywav Gets Priority Review for Idiopathic Hypersomnia
Considerable Neurologic, Psychiatric Morbidity Reported After COVID-19
FDA Rejects Pimavanserin sNDA for Dementia-Related Psychosis
FDA: Risk of Arrhythmias With Lamotrigine in Patients With Heart Disease
Tongue-Delivered Neuromodulation Therapy Gets FDA Clearance for MS-Related Gait Deficit
Drug Combo Superior to Placebo for Posttraumatic Headache
New Symptoms Common 4 Months After COVID-19
Ponvory Approved for Relapsing Forms of Multiple Sclerosis
Donanemab Studied in Early Symptomatic Alzheimer Disease
Dexmedetomidine Oral Film Gets Breakthrough Tx Status for Acute Agitation With Dementia
Fetal Exposure to Antiseizure Meds Has No Neuropsychological Impact
NeuroSphere Virtual Clinic Allows for Remote Neuromodulation Therapy Management
Neurologic Involvement Common in Children Hospitalized With COVID-19
FDA to Review Efgartigimod for Generalized Myasthenia Gravis